Atrial fibrillation patients at intermediate risk of stroke rapidly progress to high stroke risk: A nationwide registry study (AFNOR).

25 August 2023 (09:42 - 10:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Mariam Anjum

Baerum Hospital, Baerum (Norway)

4 More presentations in this session

Presentation thumbnail

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Professor G. Lip (Liverpool, GB)

Presentation thumbnail

Repeated measurement of the novel atrial biomarker BMP10 improves risk stratification in anticoagulated patients with atrial fibrillation: Insights from the ARISTOTLE trial

Doctor K. Gkarmiris (Uppsala, SE)

Abstract Slides Video

Presentation thumbnail

Development and validation of the DOAC Score: a novel bleeding risk prediction tool for patients with atrial fibrillation

Doctor R. Aggarwal (Boston, US)

Abstract Slides Video

Presentation thumbnail

Differences in causality between exposures and stroke subtypes: a mendelian randomisation approach

Associate Professor G. Klappacher (Vienna, AT)

Abstract Slides Video

Access the full session

Session thumbnail

Stroke and bleeding risk in atrial fibrillation: walking the tight rope

The Event

Event poster

ESC Congress 2023

25 August 2023 09:42 CET

You may be interested in

Congress Presentation

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Congress Session

Stroke and bleeding risk in atrial fibrillation: walking the tight rope

Congress Presentation

Does the effect of anticoagulation on stroke risk differ by CHA2DS2-VA score in patients with atrial fibrillation? A nationwide cohort study.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources